MHC molecules in DCs are necessary for an efficient tumour antigen presentation, and exosomes can be used to achieve that goal: MHC class I molecules to induce cytotoxic CD8+ T cells, and MHC class II molecules to effectively activate CD4+ T cells. Here, CD4 is linked to neoplasm.